Hence, the presence of the ST2- IL-9+ ILC2 population in the small intestine described here might be explained by this regulatory loop, where IL-33 and IL-25 are induced upon infection, promoting iILC2s that lack ST2 and express effector cytokines in vivo. The gene discussed is IL9; the disease is infection.